Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.53 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL185874 | 0.86 | IDO1 (0.55) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL3507942 | 0.83 | IDO1 (0.57) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL3507940 | 0.81 | IDO1 (0.59) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL497740 | 0.81 | IDO1 (0.50) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL29152360 | 0.74 | IDO1 (0.52) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL11791488 | 0.74 | IDO1 (0.61) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL126999 | 0.73 | IDO1 (0.67) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL28546165 | 0.72 | TSHR (0.48) | IDO1TSHRHIF1ACA12CA2 | |
| Salicyl Alcohol SCHEMBL8573675 | 0.72 | HSPA5 (0.52) | IDO1HSPA5KEAP1TSHRCYP2D6 | |
| SCHEMBL7101247 | 0.72 | IDO1 (0.64) | IDO1HSPA5KEAP1TSHRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683927-A1 | ALPHA-MODIFIED NUCLEOSIDE TRIPHOSPHATES AND METHOD FOR THEIR SYNTHESIS | Illumina, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| WO-2024196883-A1 | ALPHA-MODIFIED NUCLEOSIDE TRIPHOSPHATES AND METHOD FOR THEIR SYNTHESIS | ILLUMINA, INC. (US) | 2024-09-26 | — | — | WO | claimed |
| US-11072624-B2 | Synthesis of nucleoside 5′-triphosphates and their derivatives | SENA RESEARCH, INCORPORATED (US) | 2021-07-27 | — | — | US | claimed |
| CN-106061986-B | Novel synthetic oligomers of neisseria meningitidis serogroup X and process for their preparation | 默沙东和惠康基金会合资的希勒曼实验室私人有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-106061986-A | Novel synthetic oligomers of neisseria meningitis serogroup x and process of preparing them | 默沙东和惠康基金会合资的希勒曼实验室私人有限公司 | 2016-10-26 | — | — | CN | claimed |
| CN-103314001-B | Novel synthesis of nucleoside 5' -triphosphates and their derivatives | 塞纳研究股份有限公司 | 2016-08-17 | — | — | CN | claimed |
| CN-103314001-A | Novel synthesis of nucleoside 5' -triphosphates and their derivatives | SENA RES INC | 2013-09-18 | — | — | CN | claimed |
| US-20130158249-A1 | Novel Synthesis of Nucleoside 5'-Triphosphates and Their Derivatives | SENA RESEARCH, INCORPORATED (US) | 2013-06-20 | — | — | US | claimed |
| WO-2012024625-A2 | NOVEL SYNTHESIS OF NUCLEOSIDE 5'-TRIPHOSPHATES AND THEIR DERIVATIVES | SENA RESEARCH, INCORPORATED (US) | 2012-02-23 | — | — | WO | claimed |
| WO-2007110624-A2 | IMMOBILISED REAGENT | UNIVERSITY COURT OF THE UNIVERSITY OFEDINBURGH (GB) | 2007-10-04 | — | — | WO | claimed |
| US-20260146272-A1 | ENZYMATIC SYNTHESIS OF MODIFIED NUCLEOSIDE TRIPHOSPHATE ANALOGUES | ILLUMINA, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4683927-A1 | ALPHA-MODIFIED NUCLEOSIDE TRIPHOSPHATES AND METHOD FOR THEIR SYNTHESIS | Illumina, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250361260-A1 | NUCLEOTIDE ANALOGUES | SINGULAR GENOMICS SYSTEMS INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250346950-A1 | TAGGED NUCLEOSIDE COMPOUNDS USEFUL FOR NANOPORE DETECTION | Roche Sequencing Solutions, Inc. (US) | 2025-11-13 | — | — | US | disclosed |
| US-12270075-B2 | Tagged nucleoside compounds useful for nanopore detection | Roche Sequencing Solutions, Inc. (US) | 2025-04-08 | — | — | US | disclosed |
| WO-2002030884-A2 | SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | disclosed |
| WO-2002030860-A2 | KETONE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | disclosed |
| WO-2000059855-A1 | ETHER COMPOUNDS, COMPOSITIONS, AND USES THEREOF | ESPERION THERAPEUTICS, INC. (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-1998017281-A1 | MONOPHOSPHATE PRODRUGS OF β-L-FD4C AND β-L-FddC AS POTENT ANTIVIRAL AGENTS | VION PHARMACEUTICALS, INC. (US) | 1998-04-30 | — | — | WO | disclosed |
| WO-1996041812-A1 | OLIGONUCLEOTIDE PHOSPHORYLATION METHOD AND PRODUCTS | ISIS INNOVATION LIMITED (GB) | 1996-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346950-A1 | TAGGED NUCLEOSIDE COMPOUNDS USEFUL FOR NANOPORE DETECTION | PNP, NT5C3B, POLN | IDO1 4654/4885HSPA5 4590/4885KEAP1 4679/4885 |
| US-11072624-B2 | Synthesis of nucleoside 5′-triphosphates and their derivatives | TYMP, PNP, DCTPP1 | IDO1 2735/4885HSPA5 2564/4885KEAP1 3993/4885 |
| US-12270075-B2 | Tagged nucleoside compounds useful for nanopore detection | NT5C3B, PNP, POLN | IDO1 4688/4885HSPA5 4473/4885KEAP1 4697/4885 |
| US-20130158249-A1 | Novel Synthesis of Nucleoside 5'-Triphosphates and Their Derivatives | NUDT1, PNP, TYMP | IDO1 2875/4885HSPA5 1975/4885KEAP1 3417/4885 |
| US-20250361260-A1 | NUCLEOTIDE ANALOGUES | ADAR, NUDT1, NSUN2 | IDO1 4209/4885HSPA5 2909/4885KEAP1 4579/4885 |
| US-20260146272-A1 | ENZYMATIC SYNTHESIS OF MODIFIED NUCLEOSIDE TRIPHOSPHATE ANALOGUES | PNP, NTPCR, NME2 | IDO1 4136/4885HSPA5 3113/4885KEAP1 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.